Guiding Grace Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 51 E Shelby Street, Junction City, KY 40440 Phone: 859-325-5545 |
News Archive
Following a successful clinical trial involving Dana-Farber Cancer Institute and Brigham and Women's Hospital, the first chimeric antigen receptor (CAR) T-cell therapy for adult cancers was approved by the Food and Drug Administration today.
An artificial pancreas could soon help people living with type 2 diabetes and who also require kidney dialysis. Tests led by the University of Cambridge and Inselspital, University Hospital of Bern, Switzerland, show that the device can help patients safely and effectively manage their blood sugar levels and reduce the risk of low blood sugar levels.
The National Institute of Neurological Disorders and Stroke (NINDS) announced this week an $8 million, five-year grant to support a "National Brain and Tissue Resource for Parkinson's Disease and Related Disorders", awarded to Banner Sun Health Research Institute (BSHRI) and Mayo Clinic Arizona.
DURECT Corporation today announced that the New Drug Application for the investigational product POSIDUR (SABER-Bupivacaine) has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.
The United States faces a converging public health crisis as the nation's opioid epidemic fuels growing rates of certain infectious diseases, including HIV/AIDS, hepatitis, heart infections, and skin and soft tissue infections.
› Verified 1 days ago